Global Venous Diseases Treatment Market - Industry Trends and Forecast to 2030

Description

List of Tables

The global venous diseases treatment market is projected to register a CAGR of 7.3% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation:

Global Venous Diseases Treatment Market, By Product Type (Ablation Devices, Venous Stents, Venous Closure Products, Sclerotherapy Injection and Others), Disease Type (Deep Vein Thrombosis (DVT), Chronic Venous Insufficiency (CVI), Pulmonary Embolism, Superficial Thrombophlebitis, Varicose Veins and Others), Treatment Type (Surgeries, Scelrotherapy, Angioplasty Or Stenting, Vein Legation and Stripping, Vena Cava Filter, Ambulatory Phlebectomy, Radiofrequency Ablation Therapy, Laser Treatment and Other Therapies) End User (Hospitals, Clinics, Ambulatory Surgical Centers and Others) Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, Mexico, Germany, France, Russia, Italy, U.K., Spain, Turkey, Netherlands, Belgium, Switzerland, Ireland, Rest of Europe, China, India, Japan, Indonesia, Philippines, Thailand, Australia, Malaysia, South Korea, Singapore, Rest of Asia-Pacific, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America) Industry Trends and Forecast to 2030

Some of the major factors contributing to the growth of the venous diseases treatment market are:

Rising incidence of venous diseases

Technological advancement in the treatment of venous diseases

Increase in the geriatric population

Market Players:

The key market players for the global venous diseases treatment market are listed below:

Abbott

Alma Lasers

Angiodynamics

B.Braun Melsungen AG

Baylis Medical Company, Inc

Boston Scientific Corporation

Candela Medical

Carl Zeiss Meditec AG

Cook

Imricor

Koninklijke Philips N.V.

Medtronic

Olympus Corporation

Optimed Medizinische Instrumente GmbH

Plusmedica.de

SCITECH

Smith + Nephew

Sonablate

Stryker

Teleflex Incorporated

Terumo Corporation

Theraclion

Varian Medical Systems, Inc.

1 INTRODUCTION 52

1.1 OBJECTIVES OF THE STUDY 52
1.2 MARKET DEFINITION 52
1.3 OVERVIEW OF THE GLOBAL VENOUS DISEASES TREATMENT MARKET 52
1.4 CURRENCY AND PRICING 54
1.5 LIMITATIONS 55
1.6 MARKETS COVERED 55

2 MARKET SEGMENTATION 60

2.1 MARKETS COVERED 60
2.2 GEOGRAPHICAL SCOPE 61
2.3 YEARS CONSIDERED FOR THE STUDY 62
2.4 DBMR TRIPOD DATA VALIDATION MODEL 63
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 66
2.6 MULTIVARIATE MODELLING 67
2.7 MARKET END USER COVERAGE GRID 68
2.8 INSTRUMENT BASED LIFELINE CURVE 69
2.9 DBMR MARKET POSITION GRID 70
2.10 VENDOR SHARE ANALYSIS 72
2.11 SECONDARY SOURCES 73
2.12 ASSUMPTIONS 73

3 EXECUTIVE SUMMARY 74

4 PREMIUM INSIGHTS 77

4.1 PESTEL ANALYSIS 80
4.2 PORTER'S FIVE FORCES 81

5 GLOBAL VENOUS DISEASES TREATMENT MARKET, INDUSTRY INSIGHTS 82

6 EPIDEMIOLOGY 84

7 REGULATORY FRAMEWORK 85

8 MARKET OVERVIEW 88

8.1 DRIVERS 90
- 8.1.1 RISING INCIDENCES OF VENOUS DISEASES 90
- 8.1.2 RAPID CHANGES IN LIFESTYLE LEAD TO OBESITY RESULTING IN VENOUS DISEASES 90
- 8.1.3 INCREASE IN THE GERIATRIC POPULATION 91
- 8.1.4 TECHNOLOGICALLY ADVANCEMENT IN THE TREATMENT OF VENOUS DISEASES 92
8.2 RESTRAINTS 93
- 8.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 93
- 8.2.2 INADEQUATE REIMBURSEMENT COVERAGE 93
8.3 OPPORTUNITIES 94
- 8.3.1 RISING AWARENESS TOWARDS VENOUS DISORDERS 94
- 8.3.2 NEED FOR PROPER DIAGNOSIS AND TREATMENT OF VENOUS DISEASES 94
- 8.3.3 GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES 95
- 8.3.4 OCCUPATIONAL LIFESTYLE INCREASES THE NEED FOR VENOUS DISEASE TREATMENT 95
8.4 CHALLENGES 96
- 8.4.1 HIGH COST ASSOCIATED WITH VENOUS DISEASE TREATMENT 96
- 8.4.2 SIDE EFFECTS AND RISK ASSOCIATED WITH DIFFERENT TREATMENT MODES 97

9 GLOBAL VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE 98

9.1 OVERVIEW 99
9.2 SCLEROTHERAPY INJECTION 102
- 9.2.1 SCLEROTHERAPY, BY TYPE 102
  - 9.2.1.1 INTRAVENOUS 103
  - 9.2.1.2 INTRADERMAL 103
  - 9.2.1.3 SUBCUTANEOUS 103
- 9.2.2 SUBCUTANEOUS, BY APPLICATION 103
  - 9.2.2.1 MALFORMED LYMPHED VESSELS 103
  - 9.2.2.2 HEMORRHOIDS 103
  - 9.2.2.3 HYDROCELES 103
  - 9.2.2.4 OTHERS 103
9.3 ABLATION DEVICES 103
- 9.3.1 THERMAL ABLATION 104
  - 9.3.1.1 RADIOFREQUENCY 105
    - 9.3.1.1.1 CATHETER MANIPULATION SYSTEMS 105
    - 9.3.1.1.2 TEMPERATURE CONTROLLED 105
    - 9.3.1.1.3 FLUID COOLED 106
  - 9.3.1.2 LIGHT 106
    - 9.3.1.2.1 EXCIMER LASERS 106
    - 9.3.1.2.2 COLD LASERS 106
  - 9.3.1.3 ULTRASOUND 106
    - 9.3.1.3.1 HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) 107
    - 9.3.1.3.2 SHOCK WAVE LITHOTRIPSY 107
    - 9.3.1.3.3 MAGNETIC RESONANCE IMAGING GUIDED FOCUSED ULTRASOUND (MRI-FUS) 107
    - 9.3.1.3.4 ULTRASONIC SURGICAL SYSTEMS 107
  - 9.3.1.4 RADIATION 107
    - 9.3.1.4.1 STEREOTACTIC BODY RADIATION THERAPY 108
    - 9.3.1.4.2 INTENSITY-MODULATED RADIATION THERAPY 108
    - 9.3.1.4.3 STEREOTACTIC RADIOTHERAPY & RADIOSURGERY 108
    - 9.3.1.4.4 IMAGE GUIDED RADIATION THERAPY 108
    - 9.3.1.4.5 INTRAVASCULAR BRACHYTHERAPY 108
    - 9.3.1.4.6 PROTON BEAM THERAPY 108
  - 9.3.1.5 ELECTRICAL 108
    - 9.3.1.5.1 ELECTRICAL ABLATORS 109
    - 9.3.1.5.2 ELECTRONIC BRACHYTHERAPY 109
  - 9.3.1.6 MICROWAVE 109
  - 9.3.1.7 HYDROTHERMAL 109
- 9.3.2 NON-THERMAL ABLATION 109
  - 9.3.2.1 CRYOABLATION 109
    - 9.3.2.1.1 EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES 110
    - 9.3.2.1.2 CRYOGEN SPRAY PROBE 110
    - 9.3.2.1.3 TISSUE CONTACT PROBE 110
  - 9.3.2.2 HYDROMECHANICAL ABLATION 110
9.4 VENOUS CLOSURE PRODUCTS 110
- 9.4.1 VENOUS CLOSURE PRODUCTS, BY PROCEDURE 111
  - 9.4.1.1 INTERVENTIONAL CARDIOLOGY 111
  - 9.4.1.2 INTERVENTIONAL RADIOLOGY 111
- 9.4.2 VENOUS CLOSURE PRODUCTS, BY TECHNOLOGY 111
  - 9.4.2.1 FEMORAL ACCESS TECHNIQUE 112
  - 9.4.2.2 RADIAL ACCESS TECHNIQUE 112
9.5 VENOUS STENTS 112
- 9.5.1 VENOUS STENTS, BY TECHNOLOGY 113
  - 9.5.1.1 WALLSTENT TECHNOLOGY 113
  - 9.5.1.2 ILIAC VEIN STENT TECHNOLOGY 113
- 9.5.2 VENOUS STENTS, BY APPLICATION 113
  - 9.5.2.1 LEG 114
  - 9.5.2.2 CHEST 114
  - 9.5.2.3 ABDOMEN 114
  - 9.5.2.4 OTHERS 114
9.6 MEDICATION 114
9.7 OTHERS 115

10 GLOBAL VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE 116

10.1 OVERVIEW 117
10.2 VARICOSE VEINS 120
10.3 DEEP VEIN THROMBOSIS (DVT) 120
10.4 PULMONARY EMBOLISM 121
10.5 CHRONIC VENOUS INSUFFICIENCY (CVI) 122
10.6 SUPERFICIAL THROMBOPHLEBITIS 122
10.7 OTHERS 123

11 GLOBAL VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE 125

11.1 OVERVIEW 126
11.2 SCLEROTHERAPY 129
11.3 RADIOFREQUENCY ABLATION THERAPY 129
11.4 LASER TREATMENT 130
11.5 AMBULATORY PHLEBECTOMY 131
11.6 VEIN LIGATION AND STRIPPING 131
11.7 ANGIOPLASTY OR STENTING 132
11.8 SURGERIES 133
11.9 COMPRESSION THERAPY 133
11.10 VEINACTIVE MEDICATION 134
11.11 VENA CAVA FILTER 135
11.12 OTHER THERAPIES 136

12 GLOBAL VENOUS TREATMENT DISEASES MARKET, BY END USER 137

12.1 OVERVIEW 138
12.2 HOSPITALS 141
12.3 CLINICS 141
12.4 AMBULATORY SURGICAL CENTERS 142
12.5 OTHERS 143

13 GLOBAL VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL 144

13.1 OVERVIEW 145
13.2 DIRECT TENDER 148
13.3 RETAIL SALES 148
13.4 OTHERS 149

14 GLOBAL VENOUS DISEASES TREATMENT MARKET, BY REGION 150

14.1 OVERVIEW 151
14.2 NORTH AMERICA 156
- 14.2.1 U.S. 166
- 14.2.2 CANADA 172
- 14.2.3 MEXICO 178
14.3 EUROPE 184
- 14.3.1 GERMANY 195
- 14.3.2 U.K. 201
- 14.3.3 FRANCE 207
- 14.3.4 ITALY 213
- 14.3.5 RUSSIA 219
- 14.3.6 SPAIN 225
- 14.3.7 TURKEY 231
- 14.3.8 NETHERLANDS 237
- 14.3.9 BELGIUM 243
- 14.3.10 SWITZERLAND 249
- 14.3.11 IRELAND 255
- 14.3.12 REST OF EUROPE 261
14.4 ASIA-PACIFIC 262
- 14.4.1 CHINA 272
- 14.4.2 JAPAN 278
- 14.4.3 INDIA 284
- 14.4.4 AUSTRALIA 290
- 14.4.5 INDONESIA 296
- 14.4.6 SINGAPORE 302
- 14.4.7 MALAYSIA 308
- 14.4.8 PHILIPPINES 314
- 14.4.9 SOUTH KOREA 320
- 14.4.10 THAILAND 326
- 14.4.11 REST OF ASIA-PACIFIC 332
14.5 SOUTH AMERICA 333
- 14.5.1 BRAZIL 344
- 14.5.2 ARGENTINA 350
- 14.5.3 REST OF SOUTH AMERICA 356
14.6 MIDDLE EAST & AFRICA 357
- 14.6.1 SOUTH AFRICA 368
- 14.6.2 SAUDI ARABIA 374
- 14.6.3 U.A.E. 380
- 14.6.4 EGYPT 386
- 14.6.5 ISRAEL 392
- 14.6.6 REST OF MIDDLE EAST AND AFRICA 398

15 GLOBAL VENOUS DISEASES TREATMENT MARKET, COMPANY LANDSCAPE 399

15.1 COMPANY SHARE ANALYSIS: GLOBAL 399
15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 400
15.3 COMPANY SHARE ANALYSIS: EUROPE 401
15.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 402

16 SWOT ANALYSIS 403

17 COMPANY PROFILE 404

17.1 MEDTRONIC 404
- 17.1.1 COMPANY SNAPSHOT 404
- 17.1.2 REVENUE ANALYSIS 404
- 17.1.3 COMPANY SHARE ANALYSIS 405
- 17.1.4 PRODUCT PORTFOLIO 405
- 17.1.5 RECENT DEVELOPMENTS 405
17.2 BOSTON SCIENTIFIC CORPORATION 406
- 17.2.1 COMPANY SNAPSHOT 406
- 17.2.2 REVENUE ANALYSIS 406
- 17.2.3 COMPANY SHARE ANALYSIS 407
- 17.2.4 PRODUCT PORTFOLIO 407
- 17.2.5 RECENT DEVELOPMENTS 408
17.3 VARIAN MEDICAL SYSTEMS, INC. 409
- 17.3.1 COMPANY SNAPSHOT 409
- 17.3.2 COMPANY SHARE ANALYSIS 409
- 17.3.3 PRODUCT PORTFOLIO 410
- 17.3.4 RECENT DEVELOPMENT 410
17.4 STRYKER 411
- 17.4.1 COMPANY SNAPSHOT 411
- 17.4.2 REVENUE ANALYSIS 411
- 17.4.3 COMPANY SHARE ANALYSIS 412
- 17.4.4 PRODUCT PORTFOLIO 412
- 17.4.5 RECENT DEVELOPMENT 412
17.5 KONINKLIJKE PHILIPS N.V. 413
- 17.5.1 COMPANY SNAPSHOT 413
- 17.5.2 REVENUE ANALYSIS 413
- 17.5.3 COMPANY SHARE ANALYSIS 414
- 17.5.4 PRODUCT PORTFOLIO 414
- 17.5.5 RECENT DEVELOPMENT 414
17.6 ABBOTT 415
- 17.6.1 COMPANY SNAPSHOT 415
- 17.6.2 REVENUE ANALYSIS 415
- 17.6.3 PRODUCT PORTFOLIO 416
- 17.6.4 RECENT DEVELOPMENT 416
17.7 ALMA LASERS 417
- 17.7.1 COMPANY SNAPSHOT 417
- 17.7.2 PRODUCT PORTFOLIO 417
- 17.7.3 RECENT DEVELOPMENT 417
17.8 ANGIODYNAMICS 418
- 17.8.1 COMPANY SNAPSHOT 418
- 17.8.2 REVENUE ANALYSIS 418
- 17.8.3 PRODUCT PORTFOLIO 419
- 17.8.4 RECENT DEVELOPMENT 419
17.9 B.BRAUN MELSUNGEN AG 420
- 17.9.1 COMPANY SNAPSHOT 420
- 17.9.2 REVENUE ANALYSIS 420
- 17.9.3 PRODUCT PORTFOLIO 421
- 17.9.4 RECENT DEVELOPMENTS 421
17.10 BAYLIS MEDICAL COMPANY, INC 422
- 17.10.1 COMPANY SNAPSHOT 422
- 17.10.2 PRODUCT PORTFOLIO 422
- 17.10.3 RECENT DEVELOPMENT 422
17.11 BD 423
- 17.11.1 COMPANY SNAPSHOT 423
- 17.11.2 REVENUE ANALYSIS 423
- 17.11.3 PRODUCT PORTFOLIO 424
- 17.11.4 RECENT DEVELOPMENT 424
17.12 CANDELA MEDICAL 425
- 17.12.1 COMPANY SNAPSHOT 425
- 17.12.2 PRODUCT PORTFOLIO 425
- 17.12.3 RECENT DEVELOPMENT 425

17.13 CARL ZEISS MEDITEC AG 426
- 17.13.1 COMPANYSNAPSHOT 426
- 17.13.2 REVENUE ANALYSIS 426
- 17.13.3 PRODUCT PORTFOLIO 427
- 17.13.4 RECENT DEVELOPMENT 427
17.14 COOK 428
- 17.14.1 COMPANY SNAPSHOT 428
- 17.14.2 PRODUCT PORTFOLIO 428
- 17.14.3 RECENT DEVELOPMENTS 428
17.15 IMRICOR 429
- 17.15.1 COMPANY SNAPSHOT 429
- 17.15.2 REVENUE ANALYSIS 429
- 17.15.3 PRODUCT PORTFOLIO 430
- 17.15.4 RECENT DEVELOPMENT 430
17.16 OLYMPUS CORPORATION 431
- 17.16.1 COMPANY SNAPSHOT 431
- 17.16.2 REVENUE ANALYSIS 431
- 17.16.3 PRODUCT PORTFOILIO 432
- 17.16.4 RECENT DEVELOPMENT 432
17.17 OPTIMED MEDIZINISCHE INSTRUMENTE GMBH 433
- 17.17.1 COMPANY SNAPSHOT 433
- 17.17.2 PRODUCT PORTFOLIO 433
- 17.17.3 RECENT DEVELOPMENTS 433
17.18 PLUSMEDICA.DE 434
- 17.18.1 COMPANY SNAPSHOT 434
- 17.18.2 PRODUCT PORTFOLIO 434
- 17.18.3 RECENT DEVELOPMENT 434
17.19 SCITECH 435
- 17.19.1 COMPANY SNAPSHOT 435
- 17.19.2 PRODUCT PORTFOLIO 435
- 17.19.3 RECENT DEVELOPMENTS 435
17.20 SMITH + NEPHEW 436
- 17.20.1 COMPANY SNAPSHOT 436
- 17.20.2 REVENUE ANALYSIS 436
- 17.20.3 PRODUCT PORTFOLIO 437
- 17.20.4 RECENT DEVELOPMENT 437
17.21 SONABLATE 438
- 17.21.1 COMPANY SNAPSHOT 438
- 17.21.2 PRODUCT PORTFOLIO 438
- 17.21.3 RECENT DEVELOPMENT 438
17.22 THERACLION 439
- 17.22.1 COMPANY SNAPSHOT 439
- 17.22.2 REVENUE ANALYSIS 439
- 17.22.3 PRODUCT PORTFOLIO 440
- 17.22.4 RECENT DEVELOPMENT 440
17.23 TELEFLEX INCORPORATED 441
- 17.23.1 COMPANY SNAPSHOT 441
- 17.23.2 REVENUE ANALYSIS 441
- 17.23.3 PRODUCT PORTFOLIO 442
- 17.23.4 RECENT DEVELOPMENTS 442
17.24 TERUMO CORPORATION 443
- 17.24.1 COMPANY SNAPSHOT 443
- 17.24.2 REVENUE ANALYSIS 443
- 17.24.3 PRODUCT PORTFOLIO 444
- 17.24.4 RECENT DEVELOPMENTS 444

18 QUESTIONNAIRE 445

19 RELATED REPORTS 448

LIST OF TABLES

TABLE 1 GLOBAL VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 101
TABLE 2 GLOBAL SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 102
TABLE 3 GLOBAL SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION) 102
TABLE 4 GLOBAL SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 103
TABLE 5 GLOBAL ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 104
TABLE 6 GLOBAL ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 104
TABLE 7 GLOBAL THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 105
TABLE 8 GLOBAL RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 105
TABLE 9 GLOBAL LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 106
TABLE 10 GLOBAL ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 106
TABLE 11 GLOBAL RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 107
TABLE 12 GLOBAL ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 108
TABLE 13 GLOBAL NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 109
TABLE 14 GLOBAL CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 110
TABLE 15 GLOBAL VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 111
TABLE 16 GLOBAL VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION) 111
TABLE 17 GLOBAL VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 112
TABLE 18 GLOBAL VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 113
TABLE 19 GLOBAL VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 113
TABLE 20 GLOBAL ILIAC VEIN STENT TECHNOLOGY IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 114
TABLE 21 GLOBAL MEDICATION IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 115
TABLE 22 GLOBAL OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 115
TABLE 23 GLOBAL VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION) 119
TABLE 24 GLOBAL VARICOSE VEINS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 120
TABLE 25 GLOBAL DEEP VEIN THROMBOSIS (DVT) IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 121
TABLE 26 GLOBAL PULMONARY EMBOLISM IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 121
TABLE 27 GLOBAL CHRONIC VENOUS INSUFFICIENCY (CVI) IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 122
TABLE 28 GLOBAL SUPERFICIAL THROMBOPHLEBITIS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 123
TABLE 29 GLOBAL OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 124
TABLE 30 GLOBAL VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION) 128
TABLE 31 GLOBAL SCELEROTHERAPY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 129
TABLE 32 GLOBAL RADIOFREQUENCY ABLATION THERAPY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 130
TABLE 33 GLOBAL LASER TREATMENT IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 130
TABLE 34 GLOBAL AMBULATORY PHELEBECTOMY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 131
TABLE 35 GLOBAL VEIN LIGATION AND STRIPPING IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 132
TABLE 36 GLOBAL ANGIOPLASTY OR STENTING IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 132
TABLE 37 GLOBAL SURGERIES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 133
TABLE 38 GLOBAL COMPRESSION THERAPY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 134
TABLE 39 GLOBAL VEINACTIVE MEDICATION IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 135
TABLE 40 GLOBAL VENA CAVA FILTER IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 135
TABLE 41 GLOBAL OTHER THERAPIES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 136
TABLE 42 GLOBAL VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION) 140
TABLE 43 GLOBAL HOSPITALS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 141
TABLE 44 GLOBAL CLINICS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 142
TABLE 45 GLOBAL AMBULATORY SURGICAL CENTERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 142
TABLE 46 GLOBAL OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 143
TABLE 47 GLOBAL VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 147
TABLE 48 GLOBAL DIRECT TENDER IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 148
TABLE 49 GLOBAL RETAIL SALES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 149
TABLE 50 GLOBAL OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 149
TABLE 51 GLOBAL VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 155
TABLE 52 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 160
TABLE 53 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
TABLE 54 NORTH AMERICA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION) 160
TABLE 55 NORTH AMERICA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 160
TABLE 56 NORTH AMERICA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 161
TABLE 57 NORTH AMERICA THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 161
TABLE 58 NORTH AMERICA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 161
TABLE 59 NORTH AMERICA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 161
TABLE 60 NORTH AMERICA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 162
TABLE 61 NORTH AMERICA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 162
TABLE 62 NORTH AMERICA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 162
TABLE 63 NORTH AMERICA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 163
TABLE 64 NORTH AMERICA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 163
TABLE 65 NORTH AMERICA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION) 163
TABLE 66 NORTH AMERICA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 163
TABLE 67 NORTH AMERICA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 164
TABLE 68 NORTH AMERICA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 164
TABLE 69 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION) 164
TABLE 70 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION) 165
TABLE 71 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION) 165
TABLE 72 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 165
TABLE 73 U.S. VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 166
TABLE 74 U.S. SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION) 166
TABLE 75 U.S. SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 166
TABLE 76 U.S. ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 167
TABLE 77 U.S. THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 167
TABLE 78 U.S. RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 167
TABLE 79 U.S. LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 167
TABLE 80 U.S. ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 168
TABLE 81 U.S. RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 168
TABLE 82 U.S. ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 168
TABLE 83 U.S. NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 169
TABLE 84 U.S. CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 169
TABLE 85 U.S. VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION) 169
TABLE 86 U.S. VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 169
TABLE 87 U.S. VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 170
TABLE 88 U.S. VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 170
TABLE 89 U.S. VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION) 170
TABLE 90 U.S. VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION) 171
TABLE 91 U.S. VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION) 171
TABLE 92 U.S. VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 171
TABLE 93 CANADA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 172
TABLE 94 CANADA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION) 172
TABLE 95 CANADA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 172
TABLE 96 CANADA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 173
TABLE 97 CANADA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 173
TABLE 98 CANADA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 173
TABLE 99 CANADA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 174
TABLE 100 CANADA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 174
TABLE 101 CANADA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 174
TABLE 102 CANADA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 175
TABLE 103 CANADA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 175
TABLE 104 CANADA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION) 175
TABLE 105 CANADA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 175
TABLE 106 CANADA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 176
TABLE 107 CANADA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 176
TABLE 108 CANADA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION) 176
TABLE 109 CANADA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION) 177
TABLE 110 CANADA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION) 177
TABLE 111 CANADA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 177
TABLE 112 MEXICO VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 178
TABLE 113 MEXICO SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION) 178
TABLE 114 MEXICO SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 178
TABLE 115 MEXICO ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 179
TABLE 116 MEXICO THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 179
TABLE 117 MEXICO RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 179
TABLE 118 MEXICO LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 179
TABLE 119 MEXICO ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 180
TABLE 120 MEXICO RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 180
TABLE 121 MEXICO ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 180
TABLE 122 MEXICO NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 181
TABLE 123 MEXICO CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 181
TABLE 124 MEXICO VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION) 181
TABLE 125 MEXICO VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 181
TABLE 126 MEXICO VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 182
TABLE 127 MEXICO VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 182
TABLE 128 MEXICO VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION) 182
TABLE 129 MEXICO VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION) 183
TABLE 130 MEXICO VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION) 183
TABLE 131 MEXICO VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 183
TABLE 132 EUROPE VENOUS DISEASES TREATMENT MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 188
TABLE 133 EUROPE VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 188
TABLE 134 EUROPE SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION) 188
TABLE 135 EUROPE SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 189
TABLE 136 EUROPE ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 189
TABLE 137 EUROPE THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 189
TABLE 138 EUROPE RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 190
TABLE 139 EUROPE LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 190
TABLE 140 EUROPE ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 190
TABLE 141 EUROPE RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 191
TABLE 142 EUROPE ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 191
TABLE 143 EUROPE NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 191
TABLE 144 EUROPE CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 191
TABLE 145 EUROPE VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION) 192
TABLE 146 EUROPE VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 192
TABLE 147 EUROPE VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 192
TABLE 148 EUROPE VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 192
TABLE 149 EUROPE VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION) 193
TABLE 150 EUROPE VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION) 193
TABLE 151 EUROPE VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION) 193
TABLE 152 EUROPE VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 194
TABLE 153 GERMANY VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 195
TABLE 154 GERMANY SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION) 195
TABLE 155 GERMANY SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 195
TABLE 156 GERMANY ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 196
TABLE 157 GERMANY THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 196
TABLE 158 GERMANY RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 196
TABLE 159 GERMANY LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 196

LIST OF FIGURES

FIGURE 1 GLOBAL VENOUS DISEASES TREATMENT MARKET: SEGMENTATION 60
FIGURE 2 GLOBAL VENOUS DISEASES TREATMENT MARKET: DATA TRIANGULATION 63
FIGURE 3 GLOBAL VENOUS DISEASES TREATMENT MARKET: DROC ANALYSIS 64
FIGURE 4 GLOBAL VENOUS DISEASES TREATMENT MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 65
FIGURE 5 GLOBAL VENOUS DISEASES TREATMENT MARKET: COMPANY RESEARCH ANALYSIS 65
FIGURE 6 GLOBAL VENOUS DISEASES TREATMENT MARKET: INTERVIEW DEMOGRAPHICS 66
FIGURE 7 GLOBAL VENOUS DISEASES TREATMENT MARKET: MARKET END USER COVERAGE GRID 68
FIGURE 8 GLOBAL VENOUS DISEASES TREATMENT MARKET: DBMR MARKET POSITION GRID 70
FIGURE 9 GLOBAL VENOUS DISEASES TREATMENT MARKET: VENDOR SHARE ANALYSIS 72
FIGURE 10 GLOBAL VENOUS DISEASES TREATMENT MARKET: SEGMENTATION 76
FIGURE 11 GROWING AWARENESS ABOUT VENOUS DISEASES TREATMENTS AND INCREASING HEALTHCARE EXPENDITURE IS EXPECTED TO DRIVE THE GROWTH OF THE GLOBAL VENOUS DISEASES TREATMENT MARKET FROM 2023 TO 2030 77
FIGURE 12 THE ABLATION DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL VENOUS DISEASES TREATMENT MARKET IN 2023 & 2030 77
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL VENOUS DISEASES TREATMENT MARKET, AND ASIA PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2023 TO 2030 78
FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR GLOBAL VENOUS DISEASES TREATMENTS MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2023 TO 2030 79
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE GLOBAL VENOUS DISEASES TREATMENT MARKET 89
FIGURE 16 GLOBAL VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, 2022 99
FIGURE 17 GLOBAL VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, 2023-2030 (USD MILLION) 100
FIGURE 18 GLOBAL VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, CAGR (2023-2030) 100
FIGURE 19 GLOBAL VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, LIFELINE CURVE 101
FIGURE 20 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, 2022 117
FIGURE 21 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, 2023-2030 (USD MILLION) 118
FIGURE 22 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, CAGR (2023-2030) 118
FIGURE 23 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, LIFELINE CURVE 119
FIGURE 24 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, 2022 126
FIGURE 25 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, 2023-2030 (USD MILLION) 127
FIGURE 26 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, CAGR (2023-2030) 127
FIGURE 27 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, LIFELINE CURVE 128
FIGURE 28 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY END USER, 2022 138
FIGURE 29 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY END USER, 2023-2030 (USD MILLION) 139
FIGURE 30 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY END USER, CAGR (2023-2030) 139
FIGURE 31 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY END USER, LIFELINE CURVE 140
FIGURE 32 GLOBAL VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, 2022 145
FIGURE 33 GLOBAL VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 146
FIGURE 34 GLOBAL VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 146
FIGURE 35 GLOBAL VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE 147
FIGURE 36 GLOBAL VENOUS DISEASES TREATMENT MARKET: SNAPSHOT (2022) 152
FIGURE 37 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY REGION (2022) 153
FIGURE 38 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY REGION (2023 & 2030) 153
FIGURE 39 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY REGION (2022 & 2030) 154
FIGURE 40 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY PRODUCT TYPE (2023 & 2030) 154
FIGURE 41 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: SNAPSHOT (2022) 157
FIGURE 42 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022) 158
FIGURE 43 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2023 & 2030) 158
FIGURE 44 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022 & 2030) 159
FIGURE 45 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: PRODUCT TYPE (2023-2030) 159
FIGURE 46 EUROPE VENOUS DISEASES TREATMENT MARKET: SNAPSHOT (2022) 185
FIGURE 47 EUROPE VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022) 186
FIGURE 48 EUROPE VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2023 & 2030) 186
FIGURE 49 EUROPE VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022 & 2030) 187
FIGURE 50 EUROPE VENOUS DISEASES TREATMENT MARKET: PRODUCT TYPE (2023-2030) 187
FIGURE 51 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: SNAPSHOT (2022) 263
FIGURE 52 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022) 264
FIGURE 53 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2023 & 2030) 264
FIGURE 54 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022 & 2030) 265
FIGURE 55 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: PRODUCT TYPE (2023-2030) 265
FIGURE 56 SOUTH AMERICA VENOUS DISEASES TREATMENT MARKET: SNAPSHOT (2022) 334
FIGURE 57 SOUTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022) 335
FIGURE 58 SOUTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2023 & 2030) 335
FIGURE 59 SOUTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022 & 2030) 336
FIGURE 60 SOUTH AMERICA VENOUS DISEASES TREATMENT MARKET: PRODUCT TYPE (2023-2030) 336
FIGURE 61 MIDDLE EAST AND AFRICA VENOUS DISEASES TREATMENT MARKET: SNAPSHOT (2022) 358
FIGURE 62 MIDDLE EAST AND AFRICA VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022) 359
FIGURE 63 MIDDLE EAST AND AFRICA VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2023 & 2030) 359
FIGURE 64 MIDDLE EAST AND AFRICA VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022 & 2030) 360
FIGURE 65 MIDDLE EAST AND AFRICA VENOUS DISEASES TREATMENT MARKET: PRODUCT TYPE (2023-2030) 360
FIGURE 66 GLOBAL VENOUS DISEASES TREATMENT MARKET: COMPANY SHARE 2022 (%) 399
FIGURE 67 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: COMPANY SHARE 2022 (%) 400
FIGURE 68 EUROPE VENOUS DISEASES TREATMENT MARKET: COMPANY SHARE 2022 (%) 401
FIGURE 69 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: COMPANY SHARE 2022 (%) 402